Repros Therapeutics Inc (NASDAQ:RPRX)

8.54
Delayed Data
As of Mar 30
 -0.03 / -0.35%
Today’s Change
5.92
Today|||52-Week Range
22.55
-14.34%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close8.57
Today’s open8.64
Day’s range-- - --
Volume185,435
Average volume (3 months)323,840
Market cap$208.0M
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-4.51%
Earnings growth (this year)+13.19%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales25,957.50
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
GALEGalena Biopharma Inc+0.06+4.44%
MDGNMedgenics Inc-0.18-2.14%
ASMBAssembly Biosciences...+0.15+1.16%
FOMXFoamix Pharmaceutica...-0.03-0.32%
Data as of 03/30/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$9.0K
Annual profit (last year)-$32.5M
Net profit margin-361,500.00%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account